The Statistical Science and Quantitative Thinking Track will focus on the contributions arising from statistical science and quantitative thinking across the entire spectrum of clinical product development (drugs, diagnostic/device, and biologics).
At the conclusion of this meeting, participants should be able to:
• Identify innovative statistical solutions to issues associated with the evidence and regulatory review of drugs, diagnostics/devices, and biologics
• Describe relevant application of statistical science and quantitative thinking to the development of new therapeutic biologics,drugs, and diagnostics/devices

**Please note workshops that were made available during the Annual Meeting included attendee interactivity. Due to such format, audio recordings may not be available.